Search
Assessing author willingness to enter study information into structured data templates as part of the manuscript submission process: A pilot study
ReferenceA. Amina Wilkins , Paul Whaley , Amanda S. Persad , Ingrid L. Druwe , Janice S. Lee , Michele M. Taylor , Andrew J. Shapiro , Natalie Blanton Southard , Courtney Lemeris , Kristina A. Thayer Heliyon. 2022;8(3):e09095. doi: 10.1016/j.heliyon.2022.e09095 …
Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity
ReferenceAldert H. Piersma , Nancy C. Baker , George P. Daston , Burkhard Flick , Michio Fujiwara , Thomas B. Knudsen , Horst Spielmann , Noriyuki Suzuki , Katya Tsaioun , Hajime Kojima Current Research in Toxicology. 2022;3:100074. doi: …
Development of an Evidence-Based Risk Assessment Framework
ReferenceDaniel Krewski , Patrick Saunders-Hastings , Robert A. Baan , Tara S. Barton-Maclaren , Patience Browne , Weihsueh A. Chiu , Maureen Gwinn , Thomas Hartung , Andrew D. Kraft , Juleen Lam , R. Jeffrey Lewis , Moez Sanaa , Rebecca L. Morgan , Greg Paoli , …
Biological plausibility in environmental health systematic reviews: a GRADE concept paper
ReferencePaul Whaley , Thomas Piggott , Rebecca L. Morgan , Sebastian Hoffmann , Katya Tsaioun , Lukas Schwingshackl , Mohammed T. Ansari , Kristina A. Thayer , Holger J. Schünemann Journal of Clinical Epidemiology. 2022;146:32-46. doi: …
How evidence-based methodologies can help identify and reduce uncertainty in chemical risk assessment
ReferenceSebastian Hoffmann , Paul Whaley , Katya Tsaioun ALTEX. 2022;39(2):175-182. doi: 10.14573/altex.2201131 Evidence-based methodology, in particular systematic review, is increasingly being applied in environmental, public, and occupational health to …
Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review
ReferenceHubert Dirven , Gunn E. Vist , Sricharan Bandhakavi , Jyotsna Mehta , Seneca E. Fitch , Pandora Pound , Rebecca Ram , Breanne Kincaid , Cathalijn H. C. Leenaars , Minjun Chen , Robert A. Wright , Katya Tsaioun Scientific Reports. 2021;11(1):6403. doi: …
Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes
ReferenceRebecca L. Morgan , Paul Whaley , Kristina A. Thayer , Holger J. Schünemann Environment International. 2018;121:1027-1031. doi: 10.1016/j.envint.2018.07.015 https://www.sciencedirect.com/science/article/pii/S0160412018302046 Library Collection(s) …
Toward implementing virtual control groups in nonclinical safety studies: Workshop report and roadmap to implementation
ReferenceEmily Golden , David Allen , Alexander Amberg , Lennart T. Anger , Elizabeth Baker , Szczepan W. Baran , Frank Bringezu , Matthew Clark , Guillemette Duchateau-Nguyen , Sylvia E. Escher , Varun Giri , Armelle Grevot , Thomas Hartung , Dingzhou Li , Laura …
The high cost of prescription drugs: causes and solutions
ReferenceS. Vincent Rajkumar Blood Cancer Journal. 2020;10(6):71. doi: 10.1038/s41408-020-0338-x https://www.nature.com/articles/s41408-020-0338-x Keywords Costs and Cost Analysis Drug development Drug Industry Humans Patents as Topic Prescription Drugs United …
Innovation in the pharmaceutical industry: New estimates of R&D costs
ReferenceJoseph A. DiMasi , Henry G. Grabowski , Ronald W. Hansen Journal of Health Economics. 2016;47:20-33. doi: 10.1016/j.jhealeco.2016.01.012 The research and development costs of 106 randomly selected new drugs were obtained from a survey of 10 pharmaceutical …